shot-button
Home > Sports News > Cricket News > Article > BCCI slaps 18 month doping ban on Sangwan

BCCI slaps 18-month doping ban on Sangwan

Updated on: 20 October,2013 04:30 AM IST  | 
IANS |

The Board of Control for Cricket in India (BCCI) has banned Delhi and Kolkata Knight Riders pacer Pradeep Sangwan for 18 months after he was found violating the board's anti-doping regulations in Indian Premier League 2013.

BCCI slaps 18-month doping ban on Sangwan

Listen to this article
BCCI slaps 18-month doping ban on Sangwan
x
00:00

“The anti-doping case initiated against Sangwan by the BCCI Anti-Doping Tribunal was concluded on October 1, and the written decision issued by the Tribunal was received on October 18,” said the BCCI in a statement yesterday.

Pradeep Sangwan
Pradeep Sangwan


“The Tribunal has found that the player has committed an Anti-Doping Violation under Article 2.1 of the Code for the presence of the Prohibited Substance Stanozolol, an Anabolic Steroid,” it added.



Sangwan’s ban commenced from May 6 and it lasts till November 5, 2014, keeping him away from any BCCI-run competition, including the ones conducted by its affiliates.

The 22-year-old featured in a couple of matches for Knight Riders in 2013. He has played 38 First Class matches for Delhi besides 35 List ‘A’ games.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Did you find this article helpful?

Yes
No

Help us improve further by providing more detailed feedback and stand a chance to win a 3-month e-paper subscription! Click Here

Note: Winners will be selected via a lucky draw.

Help us improve further by providing more detailed feedback and stand a chance to win a 3-month e-paper subscription! Click Here

Note: Winners will be selected via a lucky draw.


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK